These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15343035)

  • 61. Is the addition of vasopressin to norepinephrine beneficial for the treatment of septic shock?
    Sandifer JP; Jones AE
    Ann Emerg Med; 2013 Nov; 62(5):534-535. PubMed ID: 23683544
    [No Abstract]   [Full Text] [Related]  

  • 62. Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs.
    Voelckel WG; Raedler C; Wenzel V; Lindner KH; Krismer AC; Schmittinger CA; Herff H; Rheinberger K; Königsrainer A
    Crit Care Med; 2003 Apr; 31(4):1160-5. PubMed ID: 12682488
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The role of vasopressin and the vasopressin type V1a receptor agonist selepressin in septic shock.
    Saad AF; Maybauer MO
    J Crit Care; 2017 Aug; 40():41-45. PubMed ID: 28319910
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hemodynamic Effects of Phenylephrine, Vasopressin, and Epinephrine in Children With Pulmonary Hypertension: A Pilot Study.
    Siehr SL; Feinstein JA; Yang W; Peng LF; Ogawa MT; Ramamoorthy C
    Pediatr Crit Care Med; 2016 May; 17(5):428-37. PubMed ID: 27144689
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Epinephrine in septic shock: Dr. Jekyll or Mr. Hyde?
    Levy B
    Crit Care Med; 2003 Jun; 31(6):1866-7. PubMed ID: 12794435
    [No Abstract]   [Full Text] [Related]  

  • 66. Treatment of anaphylactic shock: where is the evidence?
    Dünser MW; Torgersen C; Wenzel V
    Anesth Analg; 2008 Aug; 107(2):359-61. PubMed ID: 18633007
    [No Abstract]   [Full Text] [Related]  

  • 67. Diabetes insipidus after discontinuation of vasopressin infusion for septic shock.
    Rana H; Ferguson N; Dicpinigaitis PV
    J Clin Pharm Ther; 2018 Apr; 43(2):287-290. PubMed ID: 28895166
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vasopressor weaning in patients with septic shock.
    Arellano DL; Hanneman SK
    Crit Care Nurs Clin North Am; 2014 Sep; 26(3):413-25. PubMed ID: 25169693
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mirror, mirror on the wall: Which is the best vasopressin receptor of them all?
    Dünser MW
    Crit Care Med; 2011 Jan; 39(1):213-5. PubMed ID: 21178544
    [No Abstract]   [Full Text] [Related]  

  • 70. A century of arginine vasopressin research leading to new therapeutic strategies.
    Dünser MW; Lindner KH; Wenzel V
    Anesthesiology; 2006 Sep; 105(3):444-5. PubMed ID: 16931974
    [No Abstract]   [Full Text] [Related]  

  • 71. C-TERMINAL PORTION OF PRO-ARGININE-VASOPRESSIN (CT-PRO-AVP) AS A PREDICTIVE BIOMARKER IN SEPSIS: NOT THERE YET.
    Russell JA
    Shock; 2015 Oct; 44(4):381-2. PubMed ID: 26383890
    [No Abstract]   [Full Text] [Related]  

  • 72. Arginine-vasopressin as a rescue therapy in children with cardiocirculatory failure.
    Meyer S; Gottschling S; Gortner L
    Crit Care Med; 2007 Jul; 35(7):1800; author reply 1800. PubMed ID: 17581378
    [No Abstract]   [Full Text] [Related]  

  • 73. [Vasopressin for treatment of hemodynamic disorders].
    Adukauskiene D; Sirvinskas E; Kevelaitis E
    Medicina (Kaunas); 2008; 44(2):167-73. PubMed ID: 18344670
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Vasopressor use in septic shock: an update.
    Leone M; Martin C
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):141-7. PubMed ID: 18443479
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of terlipressin in pediatric septic shock: a review of the literature and personal experience.
    Papoff P; Mancuso M; Barbara CS; Moretti C
    Int J Immunopathol Pharmacol; 2007; 20(2):213-21. PubMed ID: 17624234
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of non-adrenergic vasopressors on macro- and microvascular coupling in distributive shock.
    Hessler M; Kampmeier TG; Rehberg S
    Best Pract Res Clin Anaesthesiol; 2016 Dec; 30(4):465-477. PubMed ID: 27931650
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Vasopressin pressor hypersensitivity in vasodilatory septic shock.
    Landry DW; Levin HR; Gallant EM; Seo S; D'Alessandro D; Oz MC; Oliver JA
    Crit Care Med; 1997 Aug; 25(8):1279-82. PubMed ID: 9267938
    [No Abstract]   [Full Text] [Related]  

  • 78. The use of terlipressin in a 14-year-old adolescent with catecholamine-resistant shock after severe traumatic brain injury.
    Meyer S; Gottschling S; Gortner L
    Acta Anaesthesiol Scand; 2007 Aug; 51(7):957. PubMed ID: 17635407
    [No Abstract]   [Full Text] [Related]  

  • 79. [Old drugs and new approval procedures: Akrinor remains marketable and an application for reapproval of Arginin Vasopressin has been made].
    Koch T; Wenzel V
    Anaesthesist; 2006 Jun; 55(6):708-10. PubMed ID: 16612644
    [No Abstract]   [Full Text] [Related]  

  • 80. Characterization and validation of a novel measure of septic shock severity.
    Bosch NA; Teja B; Wunsch H; Walkey AJ
    Intensive Care Med; 2020 Jan; 46(1):135-137. PubMed ID: 31686128
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.